Sorensen C M, Pierce C W
J Exp Med. 1982 Dec 1;156(6):1691-710. doi: 10.1084/jem.156.6.1691.
Spleen cells from C57BL/10 mice injected with syngeneic B10 L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT)-pulsed macrophages (GAT-M phi) within 18 h of birth were unable to respond to soluble GAT, GAT-methylated bovine serum albumin, or B10 GAT-M phi as adults. Spleen cells from these neonatally treated mice responded at control levels to GAT presented in allogeneic M phi and to sheep erythrocytes. Partially purified T cells from these neonatally treated mice suppressed responses by syngeneic virgin, but not primed, spleen cells in an antigen-specific manner and acted during the early phases of the response. These responder GAT-specific suppressor T cells (GAT-TSR) were sensitive to anti-Thy-1 + C and 500-rad irradiation and have the phenotype Ly-1-2+, I-J+; GAT-TSR cells can only suppress responses by spleen cells syngeneic with the GAT-TSR cells at the I-J subregion of H-2. Restimulation of these Ts cells with syngeneic GAT-M phi induces an antigen-specific suppressor factor within the supernatant fluid. The factor, GAT-TsFR, is a glycoprotein with a molecular weight between 48,000 and 63,000, as determined by gel filtration chromatography using isotonic buffers; it bears serologically detectable determinants encoded by the I-J subregion of the H-2 complex, has an antigen-binding site for GAT and L-glutamic acid50-L-tyrosine50, and shares idiotypic determinants with anti-GAT antibodies. The presence of GAT-TsFR in the first 36 h of in vitro culture is required for significant suppression. Furthermore, only responses by spleen cell syngeneic with the cells producing GAT-TsFR at the I-J subregion are suppressed. The fusion of GAT-TsFR-producing cells with BW5147 resulted in generation of two hybridomas with properties and characteristics identical to those of the conventional GAT-TsFR with one exception: conventional and hybridoma 372.D6.5 GAT-TsFR only suppress responses by spleen cells of the I-Jb haplotype, whereas suppression mediated by the second hybridoma GAT-TsFR (372.B3.5) is genetically unrestricted. These hybridoma GAT-TsFR are compared with nonresponder GAT-Ts factor (GAT-TsF) and these responder and nonresponder GAT-TsF are considered in the context of suppressor pathways.
出生后18小时内注射同基因B10 L-谷氨酸60-L-丙氨酸30-L-酪氨酸10(GAT)脉冲巨噬细胞(GAT-M phi)的C57BL/10小鼠的脾细胞,成年后对可溶性GAT、GAT甲基化牛血清白蛋白或B10 GAT-M phi无反应。这些新生期处理小鼠的脾细胞对同种异体M phi呈递的GAT和绵羊红细胞的反应处于对照水平。这些新生期处理小鼠的部分纯化T细胞以抗原特异性方式抑制同基因未致敏但非致敏脾细胞的反应,并在反应的早期阶段起作用。这些反应性GAT特异性抑制性T细胞(GAT-TSR)对抗-Thy-1+C和500拉德辐射敏感,具有Ly-1-2+、I-J+表型;GAT-TSR细胞只能在H-2的I-J亚区抑制与GAT-TSR细胞同基因的脾细胞的反应。用同基因GAT-M phi再次刺激这些Ts细胞可在上清液中诱导出一种抗原特异性抑制因子。该因子GAT-TsFR是一种糖蛋白,分子量在48000至63000之间,这是通过使用等渗缓冲液的凝胶过滤色谱法测定的;它带有由H-2复合体的I-J亚区编码的血清学可检测决定簇,具有针对GAT和L-谷氨酸50-L-酪氨酸50的抗原结合位点,并与抗GAT抗体共享独特型决定簇。在体外培养的最初36小时内存在GAT-TsFR是显著抑制所必需的。此外,只有在I-J亚区与产生GAT-TsFR的细胞同基因的脾细胞的反应才被抑制。产生GAT-TsFR的细胞与BW5147融合产生了两种杂交瘤,其特性与传统GAT-TsFR相同,但有一个例外:传统的和杂交瘤372.D6.5 GAT-TsFR仅抑制I-Jb单倍型脾细胞的反应,而第二种杂交瘤GAT-TsFR(372.B3.5)介导的抑制在遗传上不受限制。将这些杂交瘤GAT-TsFR与无反应性GAT-Ts因子(GAT-TsF)进行比较,并在抑制途径的背景下考虑这些反应性和无反应性GAT-TsF。